Cannabis Science Global Health Summit Presentations Group

Cannabis Science Global Health Summit Presentations

1375

The GHC summit at Harvard, is a yearly event designed to catalyze collaborations to eliminate...

Join Group

1375

Join Group

Activities Group Details

GHC 2018
May 2018, the Cannabis Science team participated in the 2018 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. The Global Health Catalyst (GHC) summit at Harvard, is a premier yearly event designed to catalyze high impact international collaborations to eliminate global health disparities, with main focus on cancer and related diseases. During this summit Mr. Raymond C. Dabney, the Company’s President, Chief Executive Officer (CEO), and Co-founder was named the recipient of the esteemed 2018 Harvard Global Health Catalyst (GHC) Industry Leader Award and was the keynote speaker during the Phytomedicines Session.

The theme of the Phytomedicines Session was From Farm to Bedside: Advancing Clinical Translation of Medical Cannabis and Other Phytomedicines for Global Health. Mr. Dabney discussed the development of effective cannabinoids and the creation of the Cannabis Science Global Consortium, a research and development framework and platform to cooperate and collaborate with stakeholders worldwide.
Cannabis Science’s Chief Medical Officer (CMO), Dr. Allen Herman, moderated the Phytomedicines Session and also presented on the role of cannabinoids in reducing the pain therapeutic divide between developed and developing countries, and CBIS’ research and development plan.
Pan African Ambassador for Food Security and member of the Cannabis Science Scientific Advisory Board, Dr. Brylyne Chitsunge, discussed opportunities to cultivate, extract, manufacture, package, and distribute cannabinoids in Sub-Saharan Africa along with the task of educating the rest of the continent through actions and success. The Ambassador’s main take away for the audience was the emphasis of the importance of micro-nutrition and food security within the overall approach to improve healthcare outcomes throughout all of Africa.

GHC Europe 2018
Cannabis Science participated in the Europe Global Health Catalyst (GHC) Summit and Summer Workshop in Germany, organized by at the University of Heidelberg and Harvard Medical School’s Global Health Catalyst. CBIS’ Scientific Advisory Board Member and Chief Executive Officer (CEO) of Elpasso Farms in South Africa, Dr. Brylyne Chitsunge, was invited to deliver a keynote address on engaging the African Diaspora, phytomedicines in global health, and closing the cancer pain divide. This two-day event held August 30th and 31st, is a pre-summit to the annual GHC Summit at Harvard Medical School in Boston, Massachusetts, and was attended by government officials, private-sector leaders, and researchers from Europe, the United States, and throughout Africa.
As keynote speaker, Dr. Chitsunge also discussed Elpasso Farms’ and Cannabis Science’s initiatives in Africa in the areas of food security, collaborations, and economic development. The economic development initiatives presented include education, drug development, and job creation.
Cannabis Science and Elpasso Farms have recently entered into an agreement to develop a phytomedicines initiative in South Africa. This partnership will include establishing research, development, cultivation, testing, manufacturing, and production facilities. Additionally, CBIS and Elpasso intend to establish the Pan-African Agriculture and Commerce University (PAACU), which will serve as a platform for research, drug development, education, and training throughout Africa.

Additionally, Cannabis Science, Elpasso Farms, and Harvard Medical School’s GHC recently announced the signing of a historic collaboration agreement to develop initiatives throughout

GHC 2017
April 2017, the Cannabis Science team participated in the 2017 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. Mr. Dabney was the keynote speaker and panelist for a special session on “Cannabis Science Versus Cancer and Other Malignancies”.

Mr. Dabney discussed how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science’s vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.
Additionally, Mr. Dabney presented summit participants with an overview of the company's drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). Dr. Allen Herman, Chief Medical Officer (CMO) of CBIS, Inc. Co-Chaired this session and participated in the discussion on the epidemiology of cancer and the utilization of opioids in Africa, which reflects the pain divide. Mr. Dabney and Dr. Herman lead CBIS’ collaboration with DFCI.
Category
General
Created
Thursday, 24 January 2019
Group admin
Raymond C. Dabney

Activity Stream

Thanks for your Support Kev !!!

I’ve seen a few posts and received a few emails for sure about investing right now.

Let me explain.
This is another Beautiful teachable Moment. 
I will put it like this and then we can see who a Real Shareholder is or who is Not.

PS. I think the current additional Share Purchases and Business Opportunity Options are listed in the last Newsletter.

We have made some changes.

***

ROBERT KANE will now take the lead on Financings and Share Purchases for Cannabis Science.

robert.kane@cannabisscience.com

*** Robert prefers a phone call: +1(719) 640-7360

Robert will have all current documents and pricing availability.

I am quite focused on a couple deadlines, you can cc me: raymond.dabney@cannabisscience.com

***

We are running all our projects through the Cannabis Science CSi-EDP this will help us Grow Much Faster and add compounded value to our assets.

All our Brother and Sister Companies will be Highlighted as well as ALL the New Companies joining in the CSi-EDP Company Partnership Program. Free of Charge, for now and possibly forever.

CSi-EDP is a real incubator Program for Companies in Virtually any industry to expand and/or go Public. A spot where people can register and get an education or a job in almost any country.

*** This is the True meaning of our Statement “Bringing it ALL Together!”

We just Launched the www.livenegotiator.com website through the CSi-EDP Company Partnership Program, Cannabis Science receives %percentage of all transaction fees for its CSi-EDP incubator role in the operations, growth, and structure of all LNC Projects and releases.

Everyone will get it clearly once we are underway properly. (It is Live in Beta now)
Everyone seems to want to help, no real Money though, lots of talk.

So to fix our "little" cash flow issue we launched Live Negotiator in Beta as fast as we could as a CSi-EDP Partner Company it gives us more options to strengthen our asset base and produce cash flow with cutting edge technology.

https://www.facebook.com/livenegotiator

Obviously, we don’t have a lot of time for talk, only to fix things and move forward. We will TALK all day long "if we are" fixing things and moving forward.

All our last Audited Financials are posted on the SEC website & our Website everyone knows that, and where to find them, “and still” many shareholders act like they want to help, but say "they want to see financials done first", Thanks. Great help AFTER THAT FACT.  What these "negative shareholders" are basically saying is that they want to see current financials when they are well aware that there are NONE, except for what is last posted on our SEC filings. They are well aware of this FACT; we are in process updating financials and simultaneously re-structuring and expanding our business model forward. Period.

A Great way to act like they want to help, and don’t. 
We DO NOT need to hear this. Period.

I DO get it, so I stopped speaking to existing shareholders about raising money due to the time factor, IE now. Is a bit of a shame as shareholders should be the First ones to Step up to protect their investment by investing MORE to Make Sure the Company has ENOUGH Money to move OUR Projects Forward in a Timely-Manner.

Is good to complain though, if it makes you feel better for doing Nothing except watching the struggle and complaining about it.

*** Now, if you have No Money to Invest, THIS POST is NOT for you!
*** Sit back and WATCH THE SHOW, you have a FRONT ROW Ticket.
*** Worry about NOTHING except, WHERE ARE YOUR SHARES?

*** The SEC Stated VERY clearly: ALL our shares will STAY INTACT. Period.
*** We did NOT take your Shares, they are yours, like MINE ARE MINE.
*** If you can NOT find them; the SEC will Gladly help you, they are Great!

We are ALL in this Battle Together, we Hit the Grand Slam and we are Rounding the bases, right now unfortunately, it seems there are those who do not want us to round the bases and collect our Points.

As we ALL know, Money is like Gasoline, if you run out you got issues. It depends on where you are on the road, who is in the car or truck or Ship with you. It depends on who has the money to BUY the Gas, and is there a Gas Station anywhere?

BIGGEST Question becomes; is it Worth extra money to get us to Homebase !?!!

Or is it better to just complain about it and throw rocks !?!!

*** We now have our systems in place to start sending mass emails to everyone signed up in here. Much more effective of course for sending out all our Updates, Specials, Free Samples, Beta Launch VIP, all that plus, Business Opportunities and Finance offerings.

Again, please contact Robert for Investments, we all know Mr. Robert Kane.
If not call him he is Great too!

***

Robert Kane will now take the lead on Financings and Share Purchases for Cannabis Science.

robert.kane@cannabisscience.com

Robert prefers a phone call: +1(719) 640-7360

Robert will have all current documents and pricing availability.

I am focused on a couple deadlines, you can cc me: raymond.dabney@cannabisscience.com

***

Stay Strong and Stay Safe!

CHEERS to Our Success!

Raymond C. Dabney

Thanks for your Support Kev !!!

I’ve seen a few posts and received a few emails for sure about investing right now.

Let me explain.
This is another... Show more

3 people like this.

Show previous comments (1)

Raymond C. Dabney Yeah I agree Tim. It is almost as SOLID as you can get. However, it's a bit of a solid Luxury right now. We are seriously focused on the Job at... Show more yesterday

Like 1

Yeah I agree Tim. It is almost as SOLID as you can get. However, it's a bit of a solid Luxury right now. We are seriously focused on the Job at Hand, at the Moment. There is certainly enough information to process and progress in that last issue to last till September 1, 2020, easy.

Right now, we are in the middle of serious changes, everywhere, we will put something out when there is something to report.

*** The ONLY Real change this next issue is our speculated Share Delivery date.

September 1, 2020.

This could change based on circumstance and $$$ resources, we are FOCUSED on effecting "That $$$" change for the Positive, not so much writing newsletters or explaining why "what is what" again and again and again. I think everyone tired of hearing it, I know I am.

If you haven't noticed I AM ABOUT the BE ABOUT IT !!!
That's why we got the AWARD from Harvard, because we BE ABOUT IT.
Not so MUCH the talk about it UNLESS I hear some NASTY NOISE.

I used to want to tell people what our "plans" are, especially shareholders so they seen the vision before it happens, just like we did with HARVARD.

However, sometimes it backfires with hijacked plans or canceled plans.
So we learnt our lessons there, now we give everyone enough information so you know what's up, the rest come as Surprises for good reason.

We are building up our resources to be able to offer such Luxury consistently and actually make money doing it, like the Conferences we started doing with Patients out of Time, and got HIJACKED again by the Cannabis Science and Technology Group, lawyer letters sent and the same big boy replies. Just another Nasty lawsuit like our CROP.

It is Mandatory as far as i am concerned, however it is a mandatory Luxury.

Right now at this moment, we are dealing with other Mandatory Priorities such as release our projects and creating cashflow/revenue/investment to Grow our Success. Period.

ronald barnes I see a lot of information. Why don't I know what's going on? yesterday

Tim W. H. Raymond, maybe you made a company/shareholder wide announcement there would be no July newsletter, maybe I missed it. If not, would be a good idea... Show more 10 minutes ago